Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis.
Mult Scler Relat Disord
; 63: 103814, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35487032
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Infections
/
Antibodies, Monoclonal
/
Multiple Sclerosis
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
/
Middle aged
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2022
Document type:
Article
Affiliation country:
Italia
Country of publication:
Países Bajos